ALT FY 2010 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena

ALTAltimmune, Inc.

$329M

FY 2010 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$21M-23.8% YoY

Gross Profit

$21M100.0% margin

Operating Income

-$24M-112.2% margin

Net Income

-$35M-166.0% margin

EPS (Diluted)

$-323.59

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$15M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$27M

Total Liabilities

$15M

Stockholders' Equity

$12M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21M	$28M	-23.8%
Gross Profit	$21M	$28M	-23.8%
Operating Income	-$24M	-$26M	+9.3%
Net Income	-$35M	-$32M	-8.0%